Trogocytosis: A potential pathogenic mechanism in immune thrombocytopenia leading to impaired megakaryocyte maturation and reduced platelet production

Abstract

Immune thrombocytopenia (ITP) is an autoimmune disease due to increased peripheral platelets destruction and inappropriate bone marrow production of platelets by megakaryocytes (MKs). The pathophysiology of ITP is complex and multifactorial, which remains not fully understood. However, the production of antiplatelet autoantibodies and the destruction of antibody-coated platelets through antibody-dependent cellular phagocytosis by macrophages (Mθ) expressing Fc gamma receptor (FcγR) are regarded as the key mechanisms. Glycoprotein (GP) Ⅱb/Ⅲa is the main target of antiplatelet antibodies leading to platelet phagocytosis by splenic Mθ, through interactions with FcγR. As GPⅡb/Ⅲa is normally expressed both on platelets and the MKs from which they are derived, we inferred that partial phagocytosis (definitely trogocytosis) of MKs by bone marrow Mθ might exist, leading to the increased amount of granular MKs (or non-platelets-producing MKs) in ITP. And we further hypothesized that the “bitten” MKs cannot sustain their normal function of maturation. Such trogocytosis mechanism may shed new light on the understanding of morphology alterations, maturation defects and decreased platelets production of MKs in ITP, and provide appealing implications in therapeutic modifications targeting the interplay of MKs and Mθ in bone marrow.